Silence Therapeutics

0:02:01

Executive interview – Silence Therapeutics

0:08:42

THIS IS HUGE! They Proved They Can Silence mRNA That Produce Pathogenic Proteins | STOCK TO BUY

0:11:27

Executive Interview - Silence Therapeutics

0:31:06

Silence Therapeutics (SLN) - Dr Rob Quinn, CFO

0:25:56

Silence Therapeutics (SLN) - Dr. Rob Quinn, CFO

0:22:51

Silence Therapeutics (SLN) - Dr. Rob Quinn, CFO

0:02:04

RNAi Therapeutics Market 2024: Innovation, Trend, and Growth in Gene Silencing for Disease Treatment

0:04:09

Silence Therapeutics CEO talks recent RNAi deals and updates on critical SLN124 trial

0:00:37

SILENCE THERAPEUTICS

0:35:17

Silence Therapeutics (SLN) - Dr. Rob Quinn, Interim CFO

0:07:00

Silence Therapeutics CEO on £40mln fundraise

0:00:51

Silence Therapeutics hits first milestone in Mallinckrodt deal

0:10:02

Silence Therapeutics - The GOLDen future of RNAi Research

0:44:00

Silence Therapeutics - Investor Day Presentation by MIKE KHAN

0:00:56

SILENCE THERAPEUTICS PLC Company Profile and Tech Intelligence Report, 2018

0:10:30

The $5 Stock With $6,381 Price Target! Analysts Love This Company SLN Silence Therapeutics

0:02:06

Dr Androulla Eleftheriou on International Thalassemia Day 2021

0:31:27

Silence Therapeutics - Proactive One2One Virtual Event

0:05:13

New GalNAc delivery technology 'a game-changer' says Silence Therapeutics chief

0:01:50

Silence Therapeutics: International Thalassaemia Day 2021 Video

0:00:25

🔴 Silence Therapeutics ADR Representing SLN Stock Trading Facts 🔴

0:05:35

Silence Therapeutics CEO on potential of pancreatic cancer drug

0:03:25

SLN Stock - Silence Therapeutics PLC Stock Breaking News Today | SLN Stock Price Prediction | SLN